CLINICAL_TRIALS
trial_result
· 2017-01-12
Clinical Trial Update: Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1 [Phase 2]
Summary
This update reports Phase 2 trial results evaluating desipramine ceiling dosing for cocaine-related disorders.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders, Substance-Related Disorders | Phase 2 | Status: COMPLETED